<
>
Raltitrexed (112887-68-0)
Product Summary
Raltitrexed (112887-68-0) is an anti-tumor drug for advanced colorectal cancer. Available in CP/EP specs, 98% assay, 2-year shelf life. Competitive thymidylate synthase inhibitor with selective cellular uptake.
Product Custom Attributes
CAS:
112887-68-0
Specification:
CP, EP, As Required
M.F.:
C21H22N4O6S
M.W.:
458.49
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Raltitrexed 112887-68-0
,thymidylate synthase 112887-68-0
,polyglutamate species 112887-68-0
Trading Properties
Stock:
In Stock
Shipping Method:
AIR, Express
Description:
CAS:112887-68-0; anti-tumor ; thymidylate synthase; polyglutamate species
Payment Terms:
L/C,T/T
Product Description
Raltitrexed (112887-68-0)
Raltitrexed is an anti-tumor pharmaceutical agent specifically developed for the treatment of advanced colorectal cancer. As a highly selective inhibitor of thymidylate synthase (TS), it targets the key enzyme responsible for the biochemical conversion of dUMP to dTMP. The compound enters cells via the reduced folate/methotrexate cell membrane carrier and is converted to polyglutamate species by folylpolyglutamate synthase within 4 hours, where it subsequently binds to the folate substrate site of TS.
Product Specifications
| Product Name: | Raltitrexed |
| CAS No.: | 112887-68-0 |
| Assay: | 99% |
| Specification: | CP, EP, In-house, as required |
| Molecular Formula: | C21H22N4O6S |
| Molecular Weight: | 458.49 |
| Shelf Life: | 2 Years |
| Package: | 25kg/drum |
Product Documentation
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.